This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
Home
>
Respiratory
Respiratory
Investigational COPD drug ‘shines’ at Phase 3
Treatment of idiopathic pulmonary fibrosis
Drug-resistant tuberculosis prompts caution
NICE requests more data on COPD drug
Connecting care and outcomes
Management of noisy breathing near the end of life
UKCPA position statement on AF management
UK smoke inhalation treatment failures highlighted
European Respiratory Society announce COPD winner
ERS: New drug ‘significantly increases lung function in COPD’
ERS: Moxifloxacin ‘demostrates non-inferiority for COPD’
ERS: Imatinib ‘significantly improves walking distance’
« Previous
1
…
14
15
16
17
18
…
28
Next »
Most read
1
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
2
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: